These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 1133164)
1. Uricosuric agents in uremic sera. Identification of indoxyl sulfata and hippuric acid. Boumendil-Podevin EF; Podevin RA; Richet G J Clin Invest; 1975 Jun; 55(6):1142-52. PubMed ID: 1133164 [TBL] [Abstract][Full Text] [Related]
2. Fluid secretion in isolated proximal straight renal tubules. Effect of human uremic serum. Grantham JJ; Irwin RL; Qualizza PB; Tucker DR; Whittier FC J Clin Invest; 1973 Oct; 52(10):2441-50. PubMed ID: 4738063 [TBL] [Abstract][Full Text] [Related]
3. A furan fatty acid and indoxyl sulfate are the putative inhibitors of thyroxine hepatocyte transport in uremia. Lim CF; Bernard BF; de Jong M; Docter R; Krenning EP; Hennemann G J Clin Endocrinol Metab; 1993 Feb; 76(2):318-24. PubMed ID: 8432774 [TBL] [Abstract][Full Text] [Related]
4. Secretory activity and aryl acid content of serum, urine, and cerebrospinal fluid in normal and uremic man. Porter RD; Cathcart-Rake WF; Wan SH; Whittier FC; Grantham JJ J Lab Clin Med; 1975 May; 85(5):723-31. PubMed ID: 1168235 [TBL] [Abstract][Full Text] [Related]
5. A natriuretic factor in the serum of patients with chronic uremia. Bourgoignie JJ; Hwang KH; Espinel C; Klahr S; Bricker NS J Clin Invest; 1972 Jun; 51(6):1514-27. PubMed ID: 5024044 [TBL] [Abstract][Full Text] [Related]
6. [Study on the uremic protein binding inhibitors as uremic toxin: toxic effect on erythroid colony formation, lymphocyte blast formation and renal function]. Kawashima Y Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1151-61. PubMed ID: 2533943 [TBL] [Abstract][Full Text] [Related]
7. Middle molecules in uremic serum, urine and dialysis fluid. Migone L; Dall'taglio P; Buzio C Clin Nephrol; 1975; 3(3):82-93. PubMed ID: 1139803 [TBL] [Abstract][Full Text] [Related]
8. Major role of organic anion transporter 3 in the transport of indoxyl sulfate in the kidney. Deguchi T; Ohtsuki S; Otagiri M; Takanaga H; Asaba H; Mori S; Terasaki T Kidney Int; 2002 May; 61(5):1760-8. PubMed ID: 11967025 [TBL] [Abstract][Full Text] [Related]
9. [Effect of oral sorbent, AST-120, on serum concentration of indoxyl sulfate in uremic rats]. Niwa T; Yazawa T; Maeda K; Ise M; Sugano M; Kodama T; Uehara Y Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):695-701. PubMed ID: 2120492 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of transepithelial sodium transport in the frog skin by a low molecular weight fraction of uremic serum. Bourgoignie J; Klahr S; Bricker NS J Clin Invest; 1971 Feb; 50(2):303-11. PubMed ID: 5540168 [TBL] [Abstract][Full Text] [Related]
11. Indoxyl sulfate, a circulating uremic toxin, stimulates the progression of glomerular sclerosis. Niwa T; Ise M J Lab Clin Med; 1994 Jul; 124(1):96-104. PubMed ID: 8035108 [TBL] [Abstract][Full Text] [Related]
12. Effects of uremic serum and uremic toxins on hepatic uptake of digoxin. Tsujimoto M; Kinoshita Y; Hirata S; Otagiri M; Ohtani H; Sawada Y Ther Drug Monit; 2008 Oct; 30(5):576-82. PubMed ID: 18708994 [TBL] [Abstract][Full Text] [Related]
13. Effects of pyrazinoate and p-aminohippurate on renal urate excretion by the dog and guinea pig. Perez-Gonzalez M; Weiner IM J Pharmacol Exp Ther; 1983 Feb; 224(2):364-8. PubMed ID: 6822960 [TBL] [Abstract][Full Text] [Related]
14. Indoxyl sulfate and progression of renal failure: effects of a low-protein diet and oral sorbent on indoxyl sulfate production in uremic rats and undialyzed uremic patients. Niwa T; Tsukushi S; Ise M; Miyazaki T; Tsubakihara Y; Owada A; Shiigai T Miner Electrolyte Metab; 1997; 23(3-6):179-84. PubMed ID: 9387112 [TBL] [Abstract][Full Text] [Related]
15. The presence of a natriuretic factor in urine of patients with chronic uremia. The absence of the factor in nephrotic uremic patients. Bourgoignie JJ; Hwang KH; Ipakchi E; Bricker NS J Clin Invest; 1974 Jun; 53(6):1559-67. PubMed ID: 4830222 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of renal p-aminohippurate and urate excretion in rabbits. Donoso VS; Grantham JJ J Lab Clin Med; 1986 Apr; 107(4):315-21. PubMed ID: 3958573 [TBL] [Abstract][Full Text] [Related]
17. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry. Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466 [TBL] [Abstract][Full Text] [Related]
18. Separation, identification of uremic middle molecules, and preliminary study on their toxicity. Li G; Chu J; Liu X; Yuan Z Clin Chim Acta; 2004 Dec; 350(1-2):89-98. PubMed ID: 15530464 [TBL] [Abstract][Full Text] [Related]
19. The protein metabolite hypothesis, a model for the progression of renal failure: an oral adsorbent lowers indoxyl sulfate levels in undialyzed uremic patients. Niwa T; Nomura T; Sugiyama S; Miyazaki T; Tsukushi S; Tsutsui S Kidney Int Suppl; 1997 Nov; 62():S23-8. PubMed ID: 9350673 [TBL] [Abstract][Full Text] [Related]
20. Elevated free fosphenytoin concentrations in uremic sera: uremic toxins hippuric acid and indoxyl sulfate do not account for the impaired protein binding of fosphenytoin. Dasgupta A; Havlik D Ther Drug Monit; 1998 Dec; 20(6):658-62. PubMed ID: 9853983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]